A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

Clinical trial NCT03236233 · COMPLETED

Trial details

NCT number: NCT03236233
Sponsor: Pulmocide Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2017-06-21
Primary completion: 2017-12-15
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.